Biggest News Aggregation in the World
📰 Vimla Windlass News

Vimla Windlass News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vimla Windlass. Real-time updates on events, politics, business and more.

Windlas Biotech raises over Rs 120 crore from anchor investors ahead of IPO

Windlas Biotech raises over Rs 120 crore from anchor investors ahead of IPO The company has decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according to a circular uploaded on BSE website The Initial Public Offer (IPO) comprises fresh issuance of equity shares worth Rs 165 crore (Source: PTI) PTI Updated Aug 04, 2021, 1:18 PM IST Windlas Biotech, a manufacturer of pharmaceutical formulations, on Tuesday said it has raised over Rs 1...
Dixitkumar Patel Tano India Private Equity Fund Commerce Life Insurance Company Elara India Opportunities Fund Prudential Mutual Fund Capital Markets Ltd

Krsnaa Diagnostics IPO, Windlas Biotech IPO, Devyani International IPO, Exxar Tiles IPO

4 IPOs open on Aug 4: Krsnaa Diagnostics, Windlas Biotech, Devyani International and Exxar Tiles Four IPOs will open for subscription on Wednesday (August 4). These include initial public offerings (IPOs) of Windlas Biotech, Devyani International, Krsnaa Diagnostics and Exxaro Tiles. Buoyed by bumper listings of Clean Science and Technology, GR Infraprojects, Zomato and Tatva Chintan Pharma Chem on the bourses, the four firms are expecting for their turn to make a strong debut on the Dalal Stre...
Himachal Pradesh Virag Joshi Tatva Chintan Pharma Ravi Kant Jaipuria Yum Brands Dunearn Investments Mauritius Pte Ltd

Windlas Biotech IPO opens on Aug 4, price band fixed at Rs 448-460

Windlas Biotech IPO opens on Aug 4, price band fixed at Rs 448-460 SECTIONS Share Synopsis Windlas Biotech will raise Rs 165 crore through the issuance of fresh equity shares, while promoters and existing shareholders will offload 51,42,067 equity shares via an offer-for-sale (OFS). iStock New Delhi: The initial public offering (IPO) of Windlas Biotech will hit the primary market on August 4. The price band for the same has been fixed at Rs 448-460 per share with a face value of Rs 5 each. Dehr...
New Delhi Tano India Private Equity Fund Windlas Biotech Vimla Windlass Dehradun Plant Intime India

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science